Back to Search

PETER SILVER, MD

MD

Critical Care Medicine (Internal Medicine) Physician

NPI: 1548331549Individual

Specialties, Licenses & Credentials

Critical Care Medicine (Internal Medicine) PhysicianPrimary

Internal Medicine — Critical Care Medicine

Code: 207RC0200X

170692(NY)

Research & Publications (20)

Inodilator therapy in pediatric septic shock.
PMID 12813256·Pediatr Crit Care Med·2001
8-other
Metazoan stress granule assembly is mediated by P-eIF2alpha-dependent and -independent mechanisms.
PMID 19661161·RNA·2009
7-preclinical
Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response.
PMID 19342637·J Immunol·2009
7-preclinical
Harnessing nature's toolbox: regulatory elements for synthetic biology.
PMID 19324675·J R Soc Interface·2009
6-review
Learning a prior on regulatory potential from eQTL data.
PMID 19180192·PLoS Genet·2009
8-other
Engineering a synthetic dual-organism system for hydrogen production.
PMID 19201964·Appl Environ Microbiol·2009
8-other
Synthetic biology: exploring and exploiting genetic modularity through the design of novel biological networks.
PMID 19562109·Mol Biosyst·2009
6-review
Systems-level engineering of nonfermentative metabolism in yeast.
PMID 19564482·Genetics·2009
4-observational
A conserved CCCH-type zinc finger protein regulates mRNA nuclear adenylation and export.
PMID 19364924·J Cell Biol·2009
7-preclinical
Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistance.
PMID 18404551·Med Mycol·2008
4-observational
Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
PMID 18436827·Invest Ophthalmol Vis Sci·2008
7-preclinical
Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
PMID 18390724·J Immunol·2008
7-preclinical
Preseismic velocity changes observed from active source monitoring at the Parkfield SAFOD drill site.
PMID 18615082·Nature·2008
8-other
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
PMID 18802082·J Immunol·2008
4-observational
Mouse models of experimental autoimmune uveitis.
PMID 18421234·Ophthalmic Res·2008
6-review
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
PMID 18391061·J Exp Med·2008
7-preclinical
Intron length increases oscillatory periods of gene expression in animal cells.
PMID 18703678·Genes Dev·2008
7-preclinical
Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells.
PMID 18495789·J Leukoc Biol·2008
7-preclinical
Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans.
PMID 18343803·J Antimicrob Chemother·2008
8-other
Common genetic determinants of uveitis shared with other autoimmune disorders.
PMID 18453595·J Immunol·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
SCHNEIDER CHILDREN'S HOSPITAL-PED CRITICAL CARE, 269-01 76TH AVENUE
NEW HYDE PARK, NY 11040

Location

Practice Location

SCHNEIDER CHILDREN'S HOSPITAL-PED CRITICAL CARE, NEW HYDE PARK, NY
(718) 470-3312

Quick Facts

NPI
1548331549
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile